Glomerular and tubular damage markers are elevated in patients with diabetes

Diabetes Care

Volumn 34, Issue 4, 2011, Pages 975-981

  Nauta, Ferdau L ^a   Boertien, Wendy E ^a   Bakker, Stephan J L ^a   Van Goor, Harry ^a   Van Oeveren, Wim ^a   De Jong, Paul E ^a   Bilo, Henk ^a,b   Gansevoort, Ron T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; FATTY ACID BINDING PROTEIN; HEART FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN G; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENDER; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FATTY ACID-BINDING PROTEINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 79956209682     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1545     Document Type: Article

References (25)

1. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49:S12-S154
2. American Diabetes Association. Standards of medical care in diabetes: 2007.Diabetes Care 2007;30(Suppl. 1):S4-S41
3. O'Hare AM, Hailpern SM, Pavkov ME, et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med 2010;170:930-936
4. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93 (Pubitemid 14084080)
5. Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 2005;12:177-186 (Pubitemid 40489000)
6. Comper WD, Hilliard LM, Nikolic-Paterson DJ, Russo LM. Disease-dependent mechanisms of albuminuria. Am J Physiol Renal Physiol 2008;295:F1589-F1600
7. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17:2974-2984
8. Zoja C, Garcia PB, Remuzzi G. The role of chemokines in progressive renal disease. Front Biosci 2009;14:1815-1822
9. Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009;4:873-882
10. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A; NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012-1024
11. Bagshaw SM, Bellomo R. Early diagnosis of acute kidney injury. Curr Opin Crit Care 2007;13:638-644 (Pubitemid 350059526)
12. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100 (Pubitemid 41623371)
13. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008;51:714-725
14. Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 2008;74:22-36 (Pubitemid 351841893)
15. Bolignano D, Coppolino G, Campo S, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associatedwith severity of renal disease in proteinuric patients. Nephrol Dial Transplant 2008;23:414-416 (Pubitemid 351767366)
16. Piwowar A, Knapik-Kordecka M, Fus I, Warwas M. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patientswith type 2 diabetes mellitus. Med Sci Monit 2006;12:CR210-CR214
17. Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, Hosseini R. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal 2007;21:413-417 (Pubitemid 350250411)
18. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009;32:91-98
19. Uslu S, Efe B, Alatasx O, et al. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients. J Nephrol 2005;18:559-567 (Pubitemid 41824476)
20. Brito PL, Fioretto P, Drummond K, et al. Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 1998;53:754-761 (Pubitemid 28124292)
21. Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in NIDDM patients withmicroalbuminuria.Diabetologia 1996;39:1569-1576
22. Keane WF, Zhang Z, Lyle PA, et al.; RENAAL Study Investigators. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol 2006;1:761-767
23. Lambers Heerspink HJ, Nauta FL, van der Zee CP, et al. Alkalinization of urine samples preserves albumin concentrations during prolonged frozen storage in patients with diabetes mellitus. Diabet Med 2009;26:556-559
24. Haase-Fielitz A, Haase M, Bellomo R. Instability of urinary NGAL during longterm storage. Am J Kidney Dis 2009;53:564-565; author reply 566
25. Hofstra JM, Deegens JK, Willems HL, Wetzels JF. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant 2008;23:2546-2551